Jonas Jarvius

(Mr. Jonas Jarvius)

Currently holds positions in Q Linea AB and QuiaPEG Pharmaceuticals Holding AB

Positions
Position Company Period
Chief Executive Officer Q Linea AB Jan. 1, 2008 -
Director QuiaPEG Pharmaceuticals Holding AB March 29, 2017 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-03-01 2023-02-28
SE Q Linea AB (QLINEA)
B Purchase
2
10.16
20 SEK 		2 10.16 20 SEK
2023-03-01 2023-02-28
SE Q Linea AB (QLINEA)
B Purchase
300
10.32
3,096 SEK 		300 10.32 3,096 SEK
2023-03-01 2023-02-28
SE Q Linea AB (QLINEA)
B Purchase
3,047
10.34
31,506 SEK 		3,047 10.34 31,506 SEK
2023-03-01 2023-02-28
SE Q Linea AB (QLINEA)
B Purchase
5
10.40
52 SEK 		5 10.40 52 SEK
2023-03-01 2023-02-28
SE Q Linea AB (QLINEA)
B Purchase
41,646
10.50
437,283 SEK 		41,646 10.50 437,283 SEK
2022-03-08 2022-03-08
SE Q Linea AB (QLINEA)
B Purchase
6,000
79.95
479,700 SEK 		6,000 79.95 479,700 SEK
2021-06-11 2021-06-10
SE Q Linea AB (QLINEA)
S Sale
95,000
145.40
13,813,000 SEK 		95,000 145.40 13,813,000 SEK